Published in PLoS Negl Trop Dis on November 07, 2007
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Helminth infections: the great neglected tropical diseases. J Clin Invest (2008) 6.92
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med (2008) 6.41
Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis (2009) 5.96
The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr (2010) 4.62
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis (2014) 4.01
Integrated vector management for malaria control. Malar J (2008) 3.66
Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ (2011) 3.35
Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis (2008) 3.27
The burden of human African trypanosomiasis. PLoS Negl Trop Dis (2008) 2.53
Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis (2008) 2.44
The global burden of trachoma: a review. PLoS Negl Trop Dis (2009) 2.40
The global burden of alveolar echinococcosis. PLoS Negl Trop Dis (2010) 2.31
Opisthorchis viverrini: an underestimated parasite in world health. Trends Parasitol (2008) 2.21
Snake envenoming: a disease of poverty. PLoS Negl Trop Dis (2009) 2.20
The "other" neglected diseases in global public health: surgical conditions in sub-Saharan Africa. PLoS Med (2008) 2.11
Health economics of dengue: a systematic literature review and expert panel's assessment. Am J Trop Med Hyg (2011) 2.05
Estimating the global distribution and disease burden of intestinal nematode infections: adding up the numbers--a review. Int J Parasitol (2010) 1.94
Neglected and endemic zoonoses. Philos Trans R Soc Lond B Biol Sci (2009) 1.79
Fresh approaches to anti-infective therapies. Sci Transl Med (2012) 1.67
Dengue in Thailand and Cambodia: an assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis (2011) 1.61
Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis (2008) 1.54
Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis (2012) 1.51
Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression. J Clin Invest (2009) 1.43
Potential effect of the World Health Organization's 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: a trend analysis. Bull World Health Organ (2011) 1.43
New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl Trop Dis (2009) 1.42
The Global Burden of Disease assessments--WHO is responsible? PLoS Negl Trop Dis (2007) 1.42
Combining fungal biopesticides and insecticide-treated bednets to enhance malaria control. PLoS Comput Biol (2009) 1.40
Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections. Popul Health Metr (2011) 1.37
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. Am J Trop Med Hyg (2008) 1.28
Determinants for the development of visceral leishmaniasis disease. PLoS Pathog (2013) 1.22
Analysis of risk factors for T. brucei rhodesiense sleeping sickness within villages in south-east Uganda. BMC Infect Dis (2008) 1.21
Neglected tropical diseases, neglected data sources, and neglected issues. PLoS Negl Trop Dis (2007) 1.20
Barriers to treatment access for Chagas disease in Mexico. PLoS Negl Trop Dis (2013) 1.15
Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers. Am J Trop Med Hyg (2009) 1.11
Putting health metrics into practice: using the disability-adjusted life year for strategic decision making. BMC Public Health (2013) 1.10
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. PLoS Negl Trop Dis (2008) 1.10
Effect of schistosomiasis and soil-transmitted helminth infections on physical fitness of school children in Côte d'Ivoire. PLoS Negl Trop Dis (2011) 1.09
Measuring neglect. PLoS Negl Trop Dis (2007) 1.08
Neglected tropical diseases: survey and geometry of randomised evidence. BMJ (2012) 1.07
Soil-transmitted helminth infections and physical fitness in school-aged Bulang children in southwest China: results from a cross-sectional survey. Parasit Vectors (2012) 1.07
Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease. Am J Trop Med Hyg (2010) 1.07
Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg (2015) 1.07
Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. Indian J Med Res (2012) 1.07
Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy. PLoS Negl Trop Dis (2009) 1.06
Drug discovery and development for neglected diseases: the DNDi model. Drug Des Devel Ther (2011) 1.05
The Centre for International Mental Health approach to mental health system development. Harv Rev Psychiatry (2012) 1.05
Quantifying quality of life and disability of patients with advanced schistosomiasis japonica. PLoS Negl Trop Dis (2011) 1.04
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors (2011) 1.02
Elimination of Onchocerciasis from Mexico. PLoS Negl Trop Dis (2015) 1.00
Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic. J Infect Dis (2010) 1.00
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol (2013) 0.99
Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent. PLoS Negl Trop Dis (2014) 0.99
Self-rated quality of life and school performance in relation to helminth infections: case study from Yunnan, People's Republic of China. Parasit Vectors (2010) 0.99
Regional disparities in the burden of disease attributable to unsafe water and poor sanitation in China. Bull World Health Organ (2012) 0.98
Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib. Int J Parasitol Drugs Drug Resist (2014) 0.97
First comparative transcriptomic analysis of wild adult male and female Lutzomyia longipalpis, vector of visceral leishmaniasis. PLoS One (2013) 0.96
A worm's best friend: recruitment of neutrophils by Wolbachia confounds eosinophil degranulation against the filarial nematode Onchocerca ochengi. Proc Biol Sci (2010) 0.96
Development of a novel trap for the collection of black flies of the Simulium ochraceum complex. PLoS One (2013) 0.95
Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge. Infect Immun (2011) 0.94
Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells. PLoS One (2012) 0.93
The consequences of human actions on risks for infectious diseases: a review. Infect Ecol Epidemiol (2015) 0.93
Mosquito transcriptome profiles and filarial worm susceptibility in Armigeres subalbatus. PLoS Negl Trop Dis (2010) 0.93
The emerging role of amiodarone and dronedarone in Chagas disease. Nat Rev Cardiol (2012) 0.93
Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrob Agents Chemother (2012) 0.93
The international view of envenoming in Brazil: myths and realities. J Venom Anim Toxins Incl Trop Dis (2013) 0.92
Has the NTD community neglected evidence-based policy? PLoS Negl Trop Dis (2013) 0.92
Vaccines for canine leishmaniasis. Front Immunol (2012) 0.91
Unique structure and regulation of the nematode detoxification gene regulator, SKN-1: implications to understanding and controlling drug resistance. Drug Metab Rev (2012) 0.90
Recent advances in artemisinin production through heterologous expression. Curr Med Chem (2008) 0.89
Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med (2014) 0.86
International observatory on mental health systems: a mental health research and development network. Int J Ment Health Syst (2009) 0.86
Quantifying the lack of scientific interest in neglected tropical diseases. PLoS Negl Trop Dis (2010) 0.85
Transformation of personal computers and mobile phones into genetic diagnostic systems. Anal Chem (2014) 0.85
Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda. PLoS Negl Trop Dis (2014) 0.85
Cultural drivers and health-seeking behaviours that impact on the transmission of pig-associated zoonoses in Lao People's Democratic Republic. Infect Dis Poverty (2015) 0.85
Comparative analysis of the secretome from a model filarial nematode (Litomosoides sigmodontis) reveals maximal diversity in gravid female parasites. Mol Cell Proteomics (2014) 0.85
Dual RNA-seq of parasite and host reveals gene expression dynamics during filarial worm-mosquito interactions. PLoS Negl Trop Dis (2014) 0.84
Regenerative therapies using cell sheet-based tissue engineering for cardiac disease. Cardiol Res Pract (2011) 0.84
Diversity of Anopheles mosquitoes in Binh Phuoc and Dak Nong Provinces of Vietnam and their relation to disease. Parasit Vectors (2014) 0.84
Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus. Proc Natl Acad Sci U S A (2015) 0.84
Filarial worms reduce Plasmodium infectivity in mosquitoes. PLoS Negl Trop Dis (2011) 0.84
Neglected funding for vector-borne diseases: a near miss this time, a possible disaster the next time. PLoS Negl Trop Dis (2010) 0.83
Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses. Bull World Health Organ (2014) 0.82
Evaluation of a community-based trapping program to collect Simulium ochraceum sensu lato for verification of onchocerciasis elimination. PLoS Negl Trop Dis (2014) 0.82
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity. Virology (2013) 0.81
Slaving and release in co-infection control. Parasit Vectors (2013) 0.81
Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios. Philos Trans R Soc Lond B Biol Sci (2015) 0.81
Schistosomiasis Japonica: The DALYs Recaptured. PLoS Negl Trop Dis (2008) 0.81
Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths. Vaccine (2011) 0.81
Control using genetically modified insects poses problems for regulators. PLoS Negl Trop Dis (2012) 0.80
Economic inequality caused by feedbacks between poverty and the dynamics of a rare tropical disease: the case of Buruli ulcer in sub-Saharan Africa. Proc Biol Sci (2015) 0.80
Leprosy remains an important public health challenge in India. Indian J Med Res (2013) 0.79
Health-related quality of life among school children with parasitic infections: findings from a national cross-sectional survey in Côte d'Ivoire. PLoS Negl Trop Dis (2014) 0.79
Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis. PLoS One (2015) 0.79
Phenotypic and molecular analysis of the effect of 20-hydroxyecdysone on the human filarial parasite Brugia malayi. Int J Parasitol (2016) 0.78
Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis. Front Immunol (2014) 0.78
Community Health Seeking Behavior for Suspected Human and Animal Rabies Cases, Gomma District, Southwest Ethiopia. PLoS One (2016) 0.78
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) (2003) 34.28
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet (2005) 9.45
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
A framework for assessing the performance of health systems. Bull World Health Organ (2000) 6.91
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Changes in life expectancy in Russia in the mid-1990s. Lancet (2001) 5.21
A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr (2003) 4.64
Disability-adjusted life years: a critical review. J Health Econ (1997) 4.22
Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet (1998) 3.72
On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66
Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators. Lancet (2007) 3.46
DALYs: the age-weights on balance. Bull World Health Organ (1996) 3.24
Calculating the global burden of disease: time for a strategic reappraisal? Health Econ (1999) 2.93
Measuring health and disability. Lancet (2007) 2.76
Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ (2005) 2.75
Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet (1998) 2.71
An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc Natl Acad Sci U S A (2006) 2.34
Priority setting in health care: unburdening from the burden of disease. Aust N Z J Public Health (1997) 2.23
A multi-method approach to measuring health-state valuations. Health Econ (2004) 2.10
Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ (2007) 1.70
Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data. Popul Health Metr (2003) 1.63
Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22
Gates Foundation funds new institute to evaluate global health data. BMJ (2007) 0.91
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet (2013) 18.02
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet (2006) 9.85
Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med (2006) 8.70
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Fine-particulate air pollution and life expectancy in the United States. N Engl J Med (2009) 8.36
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
What has made the population of Japan healthy? Lancet (2011) 8.18
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet (2007) 6.72
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Global sodium consumption and death from cardiovascular causes. N Engl J Med (2014) 5.83
Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70
Civil registration systems and vital statistics: successes and missed opportunities. Lancet (2007) 5.67
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet (2011) 5.13
Stillbirths: the way forward in high-income countries. Lancet (2011) 4.69
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med (2007) 4.51
Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution. Environ Sci Technol (2012) 4.44
Monitoring global health: time for new solutions. BMJ (2004) 4.39
Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med (2007) 4.35
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (2016) 4.29
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20
Inequalities in non-communicable diseases and effective responses. Lancet (2013) 4.18
National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr (2012) 4.13
Effect of air pollution control on life expectancy in the United States: an analysis of 545 U.S. counties for the period from 2000 to 2007. Epidemiology (2013) 3.93
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect (2014) 3.69
Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ (2013) 3.67
Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health (2006) 3.62
Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol (2008) 3.61
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Role of smoking in global and regional cardiovascular mortality. Circulation (2005) 3.57
Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer (2005) 3.53
Adult mortality: time for a reappraisal. Int J Epidemiol (2004) 3.41
Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr (2005) 3.31
Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ (2005) 3.30
The way forward. Lancet (2007) 3.28
Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer (2002) 3.26
Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr (2011) 3.10
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99
Stages of the cigarette epidemic on entering its second century. Tob Control (2012) 2.98
Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med (2009) 2.95
Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ (2007) 2.93
Validation of cause-of-death statistics in urban China. Int J Epidemiol (2007) 2.89
Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med (2004) 2.84
Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med (2008) 2.83
Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr (2003) 2.80
Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc (2008) 2.78
Interim measures for meeting needs for health sector data: births, deaths, and causes of death. Lancet (2007) 2.71
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66